Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
Yueshui Zhao, Sipeng Guo, Jian Min Deng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 9, pp. 3845-3858
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Advances and challenges in the treatment of lung cancer
Yuting Li, Bingshuo Yan, Shiming He
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115891-115891
Open Access | Times Cited: 139
Recent advances in non-small cell lung cancer targeted therapy; an update review
Mahmood Araghi, Reza Mannani, Ali Heidarnejad maleki, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 137
VEGF signaling: Role in angiogenesis and beyond
Pallab Shaw, Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189079-189079
Closed Access | Times Cited: 55
ROS: A “booster” for chronic inflammation and tumor metastasis
Anqi Chen, Haifeng Huang, S. S. Fang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189175-189175
Closed Access | Times Cited: 19
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
Anwen Xiong, Lei Wang, Jianhua Chen, et al.
The Lancet (2025) Vol. 405, Iss. 10481, pp. 839-849
Closed Access | Times Cited: 4
Advanced polymer hydrogels that promote diabetic ulcer healing: mechanisms, classifications, and medical applications
Yamei Xu, Qiyuan Hu, Zongyun Wei, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 31
Upregulation of HMGB1 in tumor-associated macrophages induced by tumor cell-derived lactate further promotes colorectal cancer progression
Xinyi Gao, Shiqi Zhou, Zhaofu Qin, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
Kexun Zhou, Shuo Li, Yi Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021–2023)
Jing Zeng, Qichuan Deng, Zheng Chen, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107278-107278
Closed Access | Times Cited: 14
Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy in cancer
Asmaa F. Khafaga, Mohamed M. S. Gaballa, Reham Karam, et al.
Life Sciences (2024) Vol. 341, pp. 122499-122499
Closed Access | Times Cited: 12
VEGFR affects miR-3200-3p-mediated regulatory T cell senescence in tumour-derived exosomes in non-small cell lung cancer
Kaiyuan Hui, Changhong Dong, Chenxi Hu, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 2
Closed Access | Times Cited: 9
Chemoresistance and the tumor microenvironment: the critical role of cell–cell communication
Bartosz Wilczyński, Alicja Dąbrowska, Julita Kulbacka, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
Jessica Konen, Haoyi Wu, Don L. Gibbons
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 520-536
Closed Access | Times Cited: 8
Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells
Keerakarn Somsuan, Artitaya Rongjumnong, Atthapan Morchang, et al.
Biomedical Reports (2025) Vol. 22, Iss. 5, pp. 1-11
Open Access | Times Cited: 1
Tumor Microenvironment and Cancer Metastasis
Yulong Li, Han Wu
IntechOpen eBooks (2025)
Closed Access | Times Cited: 1
A Phase 1b Study of Ivonescimab, a Programmed Cell Death Protein-1 and Vascular Endothelial Growth Factor Bispecific Antibody, as First- or Second-Line Therapy for Advanced or Metastatic Immunotherapy-Naive NSCLC
Lei Wang, Yongzhong Luo, Shengxiang Ren, et al.
Journal of Thoracic Oncology (2023) Vol. 19, Iss. 3, pp. 465-475
Open Access | Times Cited: 22
Spatiotemporal Immunomodulation and Biphasic Osteo‐Vascular Aligned Electrospun Membrane for Diabetic Periosteum Regeneration
Yusen Qiao, Lei Yu, Peng Yang, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 19
Immunotherapy Targeting PD-1/PD-L1 in Early-Stage Triple-Negative Breast Cancer
Ting-Lin Yang, Wenhui Li, Tao Huang, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 526-526
Open Access | Times Cited: 18
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
Xin Zhang, Xuemei Wang, Lijian Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Exosomes‐mediated crosstalk between glioma and immune cells in the tumor microenvironment
Xu Guo, Rui Sui, Haozhe Piao
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2074-2085
Open Access | Times Cited: 17
Neoadjuvant Immunotherapy: A Promising New Standard of Care
Emma Boydell, José Luís Sandoval, Olivier Michielin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11849-11849
Open Access | Times Cited: 17
Identification and characterization of CLEC11A and its derived immune signature in gastric cancer
Qing Yin Zheng, Zhenqi Gong, Baizhi Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway
Ju Huang, Congcong Wang, Yixuan Hou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115455-115455
Open Access | Times Cited: 15
Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway
Tianming Lu, Lirun Zhou, Zheng Chu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options
Yuan Fang, Yanxia Hu, Fei Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top